Club Drugs: Raves, Risks, and Research

National Institute on Drug Abuse and Community-Based Partners will Announce a National Research and Education Initiative about Club Drugs

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current news releases on nida.nih.gov.

Early indicators show that teens and young adults across the country are using "club drugs" - Ecstasy, Ketamine, GHB, and Rohypnol - at all night dances or "raves." These drugs, which are often used in combination with alcohol, have potentially life-threatening effects. NIDA and its partners will launch a national research and public education initiative. Later in the day, NIDA will sponsor a scientific meeting open to the news media where experts will discuss these drugs and current research.

WHAT: News Conference

WHEN: 10 A.M., Thursday, December 2, 1999

WHERE: Marriott Wardman Park Hotel, 2660 Woodley Road, N.W., Washington, DC: Room: Wilson A and B

WHO: Alan I. Leshner, Ph.D., Director, National Institute on Drug Abuse (NIDA); Bennett Leventhal, M.D., American Academy of Child and Adolescent Psychiatry (AACAP); Arthur T. Dean, Chairman and CEO, Community Anti-Drug Coalitions of America (CADCA); David Rosenbloom, Ph.D., Director, Join Together; Sue Rusche, Executive Director, National Families In Action

Also available at the news conference will be two college students involved in efforts to educate young adults about the dangers of club drugs.